These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9357349)

  • 1. Improving publicly funded substance abuse treatment: the value of case management.
    Shwartz M; Baker G; Mulvey KP; Plough A
    Am J Public Health; 1997 Oct; 87(10):1659-64. PubMed ID: 9357349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length of stay as an outcome in an era of managed care. An empirical study.
    Shwartz M; Mulvey KP; Woods D; Brannigan P; Plough A
    J Subst Abuse Treat; 1997; 14(1):11-8. PubMed ID: 9218231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of case management in the publicly funded substance abuse treatment system. The perspective of program directors, case managers and clients.
    Shwartz M; Stone DA; Camp J; Mulvey KP; Kane M; Plough A
    Care Manag J; 2000; 2(3):139-47. PubMed ID: 11398569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abstinence at Successful Discharge in Publicly Funded Addiction Health Services.
    Frimpong JA; Guerrero EG; Kong Y; Kim T
    J Behav Health Serv Res; 2016 Oct; 43(4):661-675. PubMed ID: 26882909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit determination under managed care for substance abuse treatment clients.
    McNeese-Smith DK; Crook MW; Marinelli-Casey P; Williams L; Rawson R
    Care Manag J; 2001-2002 Winter; 3(2):55-62. PubMed ID: 12455215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of acupuncture detoxification programs in a substance abuse treatment system.
    Shwartz M; Saitz R; Mulvey K; Brannigan P
    J Subst Abuse Treat; 1999 Dec; 17(4):305-12. PubMed ID: 10587932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation and retention in drug abuse treatment services research.
    Vaughn T; Sarrazin MV; Saleh SS; Huber DL; Hall JA
    J Subst Abuse Treat; 2002 Dec; 23(4):387-97. PubMed ID: 12495801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pretreatment behaviors in three treatment modalities.
    Rounds-Bryant JL; Kristiansen PL; Hubbard RL
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):573-91. PubMed ID: 10548436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients With Co-Occurring Disorders.
    Lee MT; Acevedo A; Garnick DW; Horgan CM; Panas L; Ritter GA; Campbell KM
    Psychiatr Serv; 2018 Jul; 69(7):804-811. PubMed ID: 29695226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
    McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
    Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Client outcomes from rural substance abuse treatment.
    Hiller ML; Leukefeld CG; Garrity TF; Godlaski T; Schoeneberger M; Townsend M; Hascal K
    J Psychoactive Drugs; 2007 Mar; 39(1):59-68. PubMed ID: 17523586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Iowa case management on provisions of social support for substance abuse clients.
    Sarrazin MV; Hall JA
    Care Manag J; 2004; 5(1):3-11. PubMed ID: 15792325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public managed care and service access in outpatient substance abuse treatment units.
    Chuang E; Wells R; Alexander JA
    J Behav Health Serv Res; 2011 Oct; 38(4):444-63. PubMed ID: 21184286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting readmission to substance abuse treatment using state information systems. The impact of client and treatment characteristics.
    Luchansky B; He L; Krupski A; Stark KD
    J Subst Abuse; 2000; 12(3):255-70. PubMed ID: 11367603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incentives in a public addiction treatment system: Effects on waiting time and selection.
    Stewart MT; Reif S; Dana B; Nguyen A; Torres M; Davis MT; Ritter G; Hodgkin D; Horgan CM
    J Subst Abuse Treat; 2018 Dec; 95():1-8. PubMed ID: 30352665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of case management dosage.
    Huber DL; Sarrazin MV; Vaughn T; Hall JA
    Nurs Res; 2003; 52(5):276-88. PubMed ID: 14501542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.